Cross-source evidence timeline

Bivalirudin research timeline

Follow 78 selected, directly cited source records from September 23, 1998 through November 9, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.

78Selected records
19Source years
3Evidence lanes
November 9, 2026Latest source date

Source year

2026

18 records
  1. Literature metadata

    Bivalirudin for Pediatric Procedural Anticoagulation: A Narrative Review.↗

    PubMed lists PMID 29461391 in Anesthesia and analgesia as Journal Article, Review, with publication-date metadata of 2019-01 (month precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Literature metadata

    Bivalirudin versus heparin in adult and pediatric patients with extracorporeal membrane oxygenation therapy: A systematic review and meta-analysis.↗

    PubMed lists PMID 35065202 in Pharmacological research as Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, Systematic Review, with publication-date metadata of 2022-01-20 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Literature metadata

    Bivalirudin vs. heparin in paediatric and adult patients on extracorporeal membrane oxygenation: A meta-analysis.↗

    PubMed lists PMID 35098565 in British journal of clinical pharmacology as Journal Article, Meta-Analysis, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2022-02-14 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  4. Literature metadata

    Bivalirudin versus heparin anticoagulation in patients receiving extracorporeal membrane oxygenation.↗

    PubMed lists PMID 35616224 in Perfusion as Journal Article, Meta-Analysis, with publication-date metadata of 2022-05-26 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  5. Literature metadata

    Heparin Versus Bivalirudin for Anticoagulation in Adult Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis.↗

    PubMed lists PMID 36355803 in ASAIO journal (American Society for Artificial Internal Organs : 1992) as Meta-Analysis, Systematic Review, Journal Article, with publication-date metadata of 2022-11-09 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  6. Literature metadata

    Meta-Analysis Comparing Bivalirudin Versus. Unfractionated Heparin in Adult Patients With Extracorporeal Membrane Oxygenation.↗

    PubMed lists PMID 36449392 in Journal of pharmacy practice as Meta-Analysis, Journal Article, with publication-date metadata of 2022-11-30 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  7. Literature metadata

    Bivalirudin versus heparin in STEMI after BRIGHT-4 trial: an updated meta-analysis.↗

    PubMed lists PMID 37865864 in Coronary artery disease as Meta-Analysis, Journal Article, with publication-date metadata of 2023-09-20 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  8. Literature metadata

    Bivalirudin in Extracorporeal Membrane Oxygenation.↗

    PubMed lists PMID 39259286 in Journal of cardiovascular pharmacology as Journal Article, Review, with publication-date metadata of 2024-12-01 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  9. Literature metadata

    Prospective Randomized Pilot Study Comparing Bivalirudin Versus Heparin in Neonatal and Pediatric Extracorporeal Membrane Oxygenation.↗

    PubMed lists PMID 39585174 in Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies as Journal Article, Randomized Controlled Trial, Comparative Study, with publication-date metadata of 2024-11-25 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  10. Literature metadata

    Bivalirudin Versus Heparin and Protamine in Adult Patients Undergoing Cardiac Surgery: A Systematic Review and Meta-Analysis.↗

    PubMed lists PMID 42862663 in Annals of cardiac anaesthesia as Journal Article, Systematic Review, Meta-Analysis, Comparative Study, with publication-date metadata of 2026-10-12 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  11. Clinical trials

    ClinicalTrials.gov record NCT03537586↗

    PeptideScanner retained ClinicalTrials.gov record NCT03537586 at 2026-11-15T21:58:19.888Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was bivalirudin.↗

  12. Clinical trials

    ClinicalTrials.gov record NCT04278404↗

    PeptideScanner retained ClinicalTrials.gov record NCT04278404 at 2026-11-15T21:58:19.888Z. Its registry update date was 2026-08-21, and PeptideScanner's reviewed identity mapping was bivalirudin.↗

  13. Literature metadata

    Bivalirudin as an Alternative to Heparin in Pediatric Cardiac Procedures: Evidence, Challenges, and Future Directions.↗

    PubMed lists PMID 42602128 in Sage open pediatrics as Journal Article, Review, with publication-date metadata of 2026-08-13 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  14. Clinical trials

    ClinicalTrials.gov record NCT06080074↗

    PeptideScanner retained ClinicalTrials.gov record NCT06080074 at 2026-11-15T21:58:19.888Z. Its registry update date was 2026-08-10, and PeptideScanner's reviewed identity mapping was bivalirudin.↗

  15. Literature metadata

    Ticagrelor vs. clopidogrel in bivalirudin-treated patients with STEMI undergoing primary PCI: The BRIGHT-4 trial.↗

    PubMed lists PMID 40436723 in Cardiovascular revascularization medicine : including molecular interventions as Journal Article, Comparative Study, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2025-05-10 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  16. Clinical trials

    ClinicalTrials.gov record NCT05959252↗

    PeptideScanner retained ClinicalTrials.gov record NCT05959252 at 2026-11-15T21:58:19.888Z. Its registry update date was 2026-05-08, and PeptideScanner's reviewed identity mapping was bivalirudin.↗

  17. Literature metadata

    Bivalirudin anticoagulation for cardiopulmonary bypass during cardiac surgery.↗

    PubMed lists PMID 38084653 in Perfusion as Journal Article, Review, with publication-date metadata of 2023-12-12 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  18. Clinical trials

    ClinicalTrials.gov record NCT06275555↗

    PeptideScanner retained ClinicalTrials.gov record NCT06275555 at 2026-11-15T21:58:19.888Z. Its registry update date was 2026-04-06, and PeptideScanner's reviewed identity mapping was bivalirudin.↗

Source year

2025

6 records
  1. Literature metadata

    BMI differences on anticoagulation with bivalirudin vs. heparin during primary PCI: a BRIGHT-4 subanalysis.↗

    PubMed lists PMID 41029353 in BMC medicine as Journal Article, Randomized Controlled Trial, Comparative Study, with publication-date metadata of 2025-09-30 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Regulatory

    Federal Register notice 2025-18453↗

    The Federal Register published notice 2025-18453, attributed to FDA and its parent HHS department, on 2025-09-24. Its official title is “Elite Laboratories, Inc., et al.; Withdrawal of Approval of 72 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Bivalirudin.↗

  3. Clinical trials

    ClinicalTrials.gov record NCT03822975↗

    PeptideScanner retained ClinicalTrials.gov record NCT03822975 at 2026-11-15T21:58:19.888Z. Its registry update date was 2025-08-27, and PeptideScanner's reviewed identity mapping was bivalirudin.↗

  4. Clinical trials

    ClinicalTrials.gov record NCT05984537↗

    PeptideScanner retained ClinicalTrials.gov record NCT05984537 at 2026-11-15T21:58:19.888Z. Its registry update date was 2025-08-12, and PeptideScanner's reviewed identity mapping was bivalirudin.↗

  5. Clinical trials

    ClinicalTrials.gov record NCT03532399↗

    PeptideScanner retained ClinicalTrials.gov record NCT03532399 at 2026-11-15T21:58:19.888Z. Its registry update date was 2025-07-02, and PeptideScanner's reviewed identity mapping was bivalirudin.↗

  6. Clinical trials

    ClinicalTrials.gov record NCT06861374↗

    PeptideScanner retained ClinicalTrials.gov record NCT06861374 at 2026-11-15T21:58:19.888Z. Its registry update date was 2025-03-06, and PeptideScanner's reviewed identity mapping was bivalirudin.↗

Source year

2024

2 records
  1. Literature metadata

    Bivalirudin versus heparin in patients with or without bail-out GPI use: a pre-specified subgroup analysis from the BRIGHT-4 trial.↗

    PubMed lists PMID 39334129 in BMC medicine as Journal Article, Randomized Controlled Trial, Comparative Study, Multicenter Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-09-27 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Literature metadata

    Individual Patient Data Pooled Analysis of Randomized Trials of Bivalirudin versus Heparin in Acute Myocardial Infarction: Rationale and Methodology.↗

    PubMed lists PMID 31820428 in Thrombosis and haemostasis as Comparative Study, Letter, Systematic Review, with publication-date metadata of 2019-12-09 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2023

7 records
  1. Literature metadata

    Bivalirudin Versus Heparin During PCI in NSTEMI: Individual Patient Data Meta-Analysis of Large Randomized Trials.↗

    PubMed lists PMID 37746717 in Circulation as Meta-Analysis, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2023-09-25 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Literature metadata

    Is it time to switch to bivalirudin for ECMO anticoagulation?↗

    PubMed lists PMID 37671395 in Frontiers in medicine as Journal Article, Review, with publication-date metadata of 2023-08-21 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Regulatory

    Federal Register notice 2023-19013↗

    The Federal Register published notice 2023-19013, attributed to FDA and its parent HHS department, on 2023-09-05. Its official title is “Merck Sharp & Dohme LLC, et al.; Withdrawal of Approval of 35 New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Bivalirudin.↗

  4. Clinical trials

    ClinicalTrials.gov record NCT03664180↗

    PeptideScanner retained ClinicalTrials.gov record NCT03664180 at 2026-11-15T21:58:19.888Z. Its registry update date was 2023-05-03, and PeptideScanner's reviewed identity mapping was bivalirudin.↗

  5. Literature metadata

    Comparison of Bivalirudin Versus Heparin for Anticoagulation During Extracorporeal Membrane Oxygenation.↗

    PubMed lists PMID 36194483 in ASAIO journal (American Society for Artificial Internal Organs : 1992) as Systematic Review, Meta-Analysis, Journal Article, with publication-date metadata of 2022-04-10 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  6. Literature metadata

    Heparin-based versus bivalirudin-based anticoagulation in pediatric extracorporeal membrane oxygenation: A systematic review.↗

    PubMed lists PMID 36999064 in Frontiers in medicine as Systematic Review, Journal Article, with publication-date metadata of 2023-03-14 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  7. Clinical trials

    ClinicalTrials.gov record NCT03318393↗

    PeptideScanner retained ClinicalTrials.gov record NCT03318393 at 2026-11-15T21:58:19.888Z. Its registry update date was 2023-01-31, and PeptideScanner's reviewed identity mapping was bivalirudin.↗

Source year

2022

3 records
  1. Literature metadata

    Bivalirudin in pediatric extracorporeal membrane oxygenation.↗

    PubMed lists PMID 35634698 in Current opinion in pediatrics as Journal Article, Review, with publication-date metadata of 2022-06-01 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Literature metadata

    Role of Bivalirudin for Anticoagulation in Adult Perioperative Cardiothoracic Practice.↗

    PubMed lists PMID 31521492 in Journal of cardiothoracic and vascular anesthesia as Journal Article, Review, with publication-date metadata of 2019-08-21 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Literature metadata

    Is bivalirudin an alternative anticoagulant for extracorporeal membrane oxygenation (ECMO) patients? A systematic review and meta-analysis.↗

    PubMed lists PMID 35007937 in Thrombosis research as Journal Article, Meta-Analysis, Systematic Review, with publication-date metadata of 2021-12-31 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2021

7 records
  1. Literature metadata

    Acute kidney injury in patients with acute coronary syndrome undergoing invasive management treated with bivalirudin vs. unfractionated heparin: insights from the MATRIX trial.↗

    PubMed lists PMID 34491323 in European heart journal. Acute cardiovascular care as Journal Article, Randomized Controlled Trial, with publication-date metadata of 2021-12-18 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Literature metadata

    A Review of Bivalirudin for Pediatric and Adult Mechanical Circulatory Support.↗

    PubMed lists PMID 33174088 in American journal of cardiovascular drugs : drugs, devices, and other interventions as Journal Article, Review, with publication-date metadata of 2020-11-10 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Clinical trials

    ClinicalTrials.gov record NCT03588611↗

    PeptideScanner retained ClinicalTrials.gov record NCT03588611 at 2026-11-15T21:58:19.888Z. Its registry update date was 2021-08-09, and PeptideScanner's reviewed identity mapping was bivalirudin.↗

  4. Literature metadata

    Meta-analysis of bivalirudin versus heparin in transradial coronary interventions.↗

    PubMed lists PMID 32091668 in Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions as Journal Article, Meta-Analysis, Systematic Review, with publication-date metadata of 2020-02-24 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  5. Literature metadata

    The Use of Bivalirudin in Pediatric Cardiac Surgery and in the Interventional Cardiology Suite.↗

    PubMed lists PMID 32127273 in Journal of cardiothoracic and vascular anesthesia as Journal Article, Review, with publication-date metadata of 2020-01-21 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  6. Regulatory

    Drugs@FDA application ANDA213078↗

    The official Drugs@FDA dataset lists original submission 1 for ANDA 213078 with status AP dated 2021-05-28, and names bivalirudin among the application record's active ingredients.↗

  7. Literature metadata

    Bivalirudin Versus Heparin During Intervention in Acute Coronary Syndrome: A Systematic Review of Randomized Trials.↗

    PubMed lists PMID 31241442 in Cardiovascular & hematological disorders drug targets as Journal Article, Systematic Review, with publication-date metadata of 2020 (year precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2020

2 records
  1. Literature metadata

    Bivalirudin Versus Heparin Monotherapy in Elderly Patients With Myocardial Infarction: A Prespecified Subgroup Analysis of the VALIDATE-SWEDEHEART Trial.↗

    PubMed lists PMID 32216471 in Circulation. Cardiovascular interventions as Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2020-03-27 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Literature metadata

    Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis of CTB-001, a Recently Developed Generic of Bivalirudin.↗

    PubMed lists PMID 31396727 in Pharmaceutical research as Clinical Trial, Phase I, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2019-08-08 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2019

2 records
  1. Regulatory

    Drugs@FDA application ANDA210031↗

    The official Drugs@FDA dataset lists original submission 1 for ANDA 210031 with status AP dated 2019-10-23, and names bivalirudin among the application record's active ingredients.↗

  2. Regulatory

    Drugs@FDA application NDA211215↗

    The official Drugs@FDA dataset lists original submission 1 for NDA 211215 with status AP dated 2019-07-25, and names bivalirudin among the application record's active ingredients.↗

Source year

2018

4 records
  1. Clinical trials

    ClinicalTrials.gov record NCT00073580↗

    PeptideScanner retained ClinicalTrials.gov record NCT00073580 at 2026-11-15T21:58:19.888Z. Its registry update date was 2018-11-30, and PeptideScanner's reviewed identity mapping was bivalirudin.↗

  2. Regulatory

    Drugs@FDA application ANDA205962↗

    The official Drugs@FDA dataset lists original submission 1 for ANDA 205962 with status AP dated 2018-07-27, and names bivalirudin among the application record's active ingredients.↗

  3. Regulatory

    Drugs@FDA application ANDA091602↗

    The official Drugs@FDA dataset lists original submission 1 for ANDA 091602 with status AP dated 2018-07-16, and names bivalirudin among the application record's active ingredients.↗

  4. Regulatory

    Drugs@FDA application ANDA202471↗

    The official Drugs@FDA dataset lists original submission 1 for ANDA 202471 with status AP dated 2018-06-01, and names bivalirudin among the application record's active ingredients.↗

Source year

2017

8 records
  1. Regulatory

    Drugs@FDA application NDA208374↗

    The official Drugs@FDA dataset lists original submission 1 for NDA 208374 with status AP dated 2017-12-21, and names bivalirudin among the application record's active ingredients.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT00433966↗

    PeptideScanner retained ClinicalTrials.gov record NCT00433966 at 2026-11-15T21:58:19.888Z. Its registry update date was 2017-12-04, and PeptideScanner's reviewed identity mapping was bivalirudin.↗

  3. Regulatory

    Drugs@FDA application ANDA206551↗

    The official Drugs@FDA dataset lists original submission 1 for ANDA 206551 with status AP dated 2017-11-22, and names bivalirudin among the application record's active ingredients.↗

  4. Regulatory

    Drugs@FDA application ANDA204876↗

    The official Drugs@FDA dataset lists original submission 1 for ANDA 204876 with status AP dated 2017-07-06, and names bivalirudin among the application record's active ingredients.↗

  5. Regulatory

    Drugs@FDA application ANDA201577↗

    The official Drugs@FDA dataset lists original submission 1 for ANDA 201577 with status AP dated 2017-05-26, and names bivalirudin among the application record's active ingredients.↗

  6. Clinical trials

    ClinicalTrials.gov record NCT02311231↗

    PeptideScanner retained ClinicalTrials.gov record NCT02311231 at 2026-11-15T21:58:19.888Z. Its registry update date was 2017-05-19, and PeptideScanner's reviewed identity mapping was bivalirudin.↗

  7. Clinical trials

    ClinicalTrials.gov record NCT01651780↗

    PeptideScanner retained ClinicalTrials.gov record NCT01651780 at 2026-11-15T21:58:19.888Z. Its registry update date was 2017-04-07, and PeptideScanner's reviewed identity mapping was bivalirudin.↗

  8. Clinical trials

    ClinicalTrials.gov record NCT02384070↗

    PeptideScanner retained ClinicalTrials.gov record NCT02384070 at 2026-11-15T21:58:19.888Z. Its registry update date was 2017-02-03, and PeptideScanner's reviewed identity mapping was bivalirudin.↗

Source year

2016

4 records
  1. Regulatory

    Drugs@FDA application ANDA090189↗

    The official Drugs@FDA dataset lists original submission 1 for ANDA 090189 with status AP dated 2016-10-28, and names bivalirudin among the application record's active ingredients.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT00812370↗

    PeptideScanner retained ClinicalTrials.gov record NCT00812370 at 2026-11-15T21:58:19.888Z. Its registry update date was 2016-07-15, and PeptideScanner's reviewed identity mapping was bivalirudin.↗

  3. Clinical trials

    ClinicalTrials.gov record NCT01848899↗

    PeptideScanner retained ClinicalTrials.gov record NCT01848899 at 2026-11-15T21:58:19.888Z. Its registry update date was 2016-04-06, and PeptideScanner's reviewed identity mapping was bivalirudin.↗

  4. Clinical trials

    ClinicalTrials.gov record NCT01087723↗

    PeptideScanner retained ClinicalTrials.gov record NCT01087723 at 2026-11-15T21:58:19.888Z. Its registry update date was 2016-02-12, and PeptideScanner's reviewed identity mapping was bivalirudin.↗

Source year

2015

4 records
  1. Regulatory

    Drugs@FDA application ANDA090811↗

    The official Drugs@FDA dataset lists original submission 1 for ANDA 090811 with status AP dated 2015-07-14, and names bivalirudin among the application record's active ingredients.↗

  2. Regulatory

    Drugs@FDA application ANDA090816↗

    The official Drugs@FDA dataset lists original submission 1 for ANDA 090816 with status AP dated 2015-07-14, and names bivalirudin among the application record's active ingredients.↗

  3. Clinical trials

    ClinicalTrials.gov record NCT00616460↗

    PeptideScanner retained ClinicalTrials.gov record NCT00616460 at 2026-11-15T21:58:19.888Z. Its registry update date was 2015-06-12, and PeptideScanner's reviewed identity mapping was bivalirudin.↗

  4. Clinical trials

    ClinicalTrials.gov record NCT01519518↗

    PeptideScanner retained ClinicalTrials.gov record NCT01519518 at 2026-11-15T21:58:19.888Z. Its registry update date was 2015-05-13, and PeptideScanner's reviewed identity mapping was bivalirudin.↗

Source year

2014

1 record
  1. Clinical trials

    ClinicalTrials.gov record NCT01465503↗

    PeptideScanner retained ClinicalTrials.gov record NCT01465503 at 2026-11-15T21:58:19.888Z. Its registry update date was 2014-04-08, and PeptideScanner's reviewed identity mapping was bivalirudin.↗

Source year

2012

2 records
  1. Clinical trials

    ClinicalTrials.gov record NCT00373451↗

    PeptideScanner retained ClinicalTrials.gov record NCT00373451 at 2026-11-15T21:58:19.888Z. Its registry update date was 2012-05-08, and PeptideScanner's reviewed identity mapping was bivalirudin.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT00079586↗

    PeptideScanner retained ClinicalTrials.gov record NCT00079586 at 2026-11-15T21:58:19.888Z. Its registry update date was 2012-01-05, and PeptideScanner's reviewed identity mapping was bivalirudin.↗

Source year

2011

3 records
  1. Clinical trials

    ClinicalTrials.gov record NCT00073593↗

    PeptideScanner retained ClinicalTrials.gov record NCT00073593 at 2026-11-15T21:58:19.888Z. Its registry update date was 2011-11-10, and PeptideScanner's reviewed identity mapping was bivalirudin.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT00503126↗

    PeptideScanner retained ClinicalTrials.gov record NCT00503126 at 2026-11-15T21:58:19.888Z. Its registry update date was 2011-11-10, and PeptideScanner's reviewed identity mapping was bivalirudin.↗

  3. Clinical trials

    ClinicalTrials.gov record NCT00043940↗

    PeptideScanner retained ClinicalTrials.gov record NCT00043940 at 2026-11-15T21:58:19.888Z. Its registry update date was 2011-09-16, and PeptideScanner's reviewed identity mapping was bivalirudin.↗

Source year

2010

2 records
  1. Regulatory

    Federal Register notice 2010-31583↗

    The Federal Register published notice 2010-31583, attributed to FDA and its parent HHS department, on 2010-12-16. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; ANGIOMAX,” and PeptideScanner's exact reviewed identity mapping connects the document to Bivalirudin.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT00262054↗

    PeptideScanner retained ClinicalTrials.gov record NCT00262054 at 2026-11-15T21:58:19.888Z. Its registry update date was 2010-03-15, and PeptideScanner's reviewed identity mapping was bivalirudin.↗

Source year

2009

1 record
  1. Clinical trials

    ClinicalTrials.gov record NCT00448461↗

    PeptideScanner retained ClinicalTrials.gov record NCT00448461 at 2026-11-15T21:58:19.888Z. Its registry update date was 2009-02-10, and PeptideScanner's reviewed identity mapping was bivalirudin.↗

Source year

2000

1 record
  1. Regulatory

    Drugs@FDA application NDA020873↗

    The official Drugs@FDA dataset lists original submission 1 for NDA 020873 with status AP dated 2000-12-15, and names bivalirudin among the application record's active ingredients.↗

Source year

1998

1 record
  1. Regulatory

    Federal Register notice 98-25360↗

    The Federal Register published notice 98-25360, attributed to FDA and its parent HHS department, on 1998-09-23. Its official title is “Cardiovascular and Renal Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Bivalirudin.↗